Experts urge UK prime minister to act on 'massive' rises in the prices of drugs for rare diseases

An open letter from 20 consultants and a patient group published in the British Medical Journal today, calls on the prime minister to take action over a legal loophole that allows drug companies to make easy profits by licensing existing treatments for rare (orphan) diseases.

Read the whole article on Physorg

More from Physorg